What is the current market size?

The Lumpectomy Device market size was valued at USD 1.2 billion in 2023, reflecting strong adoption of minimally invasive surgical tools in oncology.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2032, driven by rising breast cancer incidence and advanced device innovations.

What are the key growth drivers?

Key drivers include increased awareness of breast health, rising geriatric populations, and technological advancements in precision surgical tools.

What challenges hinder market growth?

High device costs, regulatory complexities, and the need for specialized training limit market expansion, especially in low-income regions.

Which regions lead the market?

North America dominates the market, followed by Europe, due to well-established healthcare systems and high surgical adoption rates.

Who are the top companies?

Leading firms include Medtronic, Ethicon, and Olympus, which focus on R&D to enhance device functionality and user experience.

What future opportunities exist?

Emerging markets in Asia-Pacific and Latin America offer untapped potential due to growing healthcare access and rising disposable incomes.

How does technology impact the market?

AI integration, robotic-assisted surgery, and 3D imaging are transforming lumpectomy devices, improving surgical accuracy and recovery times.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA enforce strict approval processes, ensuring safety but prolonging market entry timelines for new devices.

Lumpectomy Device Expansion Opportunities & Forecast Analysis 2033

Lumpectomy Device by Application (Hospitals, Ambulatory Surgical Centers), by Types (Lumpectomy Systems, Lumpectomy Surgical Tools), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Lumpectomy Device Market Size | CAGR 9.8 Forecast 2033

Lumpectomy Device Expansion Opportunities & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Lumpectomy Device Market Overview

The Lumpectomy Device market encompasses surgical instruments and systems designed for breast-conserving tumor excision, addressing a critical need in oncology care. As a cornerstone of breast cancer treatment, lumpectomy devices are integral to minimizing tissue removal while maximizing diagnostic accuracy. The Lumpectomy Device market size is projected to expand significantly, driven by rising breast cancer prevalence, advancements in minimally invasive technologies, and growing preference for outpatient procedures. The growth outlook for the industry remains robust, with a market forecast indicating a compound annual growth rate (CAGR) of 5.8% from 2026–2033, reflecting sustained industry expansion across developed and emerging economies.

Loading chart…

North America currently dominates the Lumpectomy Device market, fueled by well-established healthcare infrastructure and high adoption of advanced surgical tools. Conversely, Asia-Pacific is emerging as the fastest-growing region, spurred by rising healthcare accessibility, urbanization, and government initiatives to combat cancer. Key forces shaping the industry include technological innovation in imaging-guided devices, regulatory harmonization for device approvals, and shifting consumer preferences toward less invasive procedures. Strategic partnerships among device manufacturers and oncology centers further underscore competitive intensity, positioning the market for long-term industry expansion amid evolving clinical guidelines and patient-centric care models.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.54 billion
Growth rate	CAGR of 9.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Hologic; BD; Danaher; Carl Zeiss Meditech; Merit Medical; Argon Medical Devices; Sanarus; Endomagnetics; SOMATEX Medical; Ranfac; STERYLAB
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising incidence of breast cancer is a primary catalyst for the Lumpectomy Device market, with global breast cancer cases projected to exceed 2.8 million by 2030, per WHO data. This surge is fueling demand for minimally invasive surgical tools that reduce hospital stays and improve patient outcomes.

Technological advancements in precision-guided devices are accelerating adoption, particularly in high-income regions. Innovations such as real-time imaging integration and robotic-assisted lumpectomy systems are enhancing procedure accuracy, driving market expansion, and supporting a growth forecast of 6.8% CAGR through 2032.

Restraints2 items

High device costs and limited reimbursement coverage in emerging economies are restraining market penetration. Advanced lumpectomy systems require significant capital investment, deterring adoption in budget-constrained healthcare settings.

Regulatory delays in product approvals, particularly in the EU and Asia-Pacific regions, are slowing commercialization. Stringent clinical validation requirements for new surgical technologies are elongating time-to-market for innovators.

Opportunities2 items

Emerging markets like India and Brazil present untapped potential, driven by rising healthcare private-sector investments and expanding access to specialized oncology care. Strategic partnerships with local distributors could unlock significant Lumpectomy Device market size growth.

Personalized medicine trends are creating demand for modular lumpectomy devices tailored to tumor size and patient anatomy. Customizable systems could capture a premium pricing niche while addressing unmet clinical needs in complex cases.

Challenges2 items

Price sensitivity among hospitals is intensifying, with payers pressuring providers to adopt cost-effective solutions. This is eroding profit margins for premium devices and forcing manufacturers to offer tiered pricing models.

Supply chain fragility due to reliance on single-source components for precision instruments poses risks. Geopolitical disruptions or material shortages could delay production, impacting revenue visibility in the Lumpectomy Device market.

Market Segmentation

Loading chart…

Application in the Lumpectomy Device market is categorized into Breast Cancer Treatment and Benign Tumor Removal. Breast cancer treatment accounts for the largest share, driven by rising incidence rates and advancements in minimally invasive techniques. Lumpectomy Device segmentation by application highlights that breast cancer procedures require precision tools for tumor excision and margin assessment, while benign tumor removal focuses on cost-effective solutions for non-malignant cases. The benign segment is expected to grow due to increased diagnostic accuracy and awareness. These sub-segments collectively shape market dynamics by influencing R&D priorities and adoption trends.

Types of Lumpectomy Devices are divided into Surgical Devices and Imaging-Guided Devices. Surgical devices include biopsy needles, tissue harvesters, and excisional tools, which dominate the market due to their widespread use in standard procedures. Imaging-guided devices, such as MRI-compatible or ultrasound-assisted tools, represent a niche but high-growth segment, driven by demand for real-time precision in complex cases. Market taxonomy analysis reveals that surgical devices contribute ~70% to revenue, while imaging-guided solutions capture 30%, reflecting their premium pricing and specialized applications. This segmentation underscores the market’s reliance on technological innovation and procedural complexity.

Lumpectomy Device Segmentation Breakdown6 items

Application

Hospitals

Ambulatory Surgical Centers

Types

Lumpectomy Systems

Lumpectomy Surgical Tools

Regional Insights

Loading chart…

The Lumpectomy Device market is dominated by North America, which leads with a 35% share, driven by advanced healthcare infrastructure, high cancer incidence rates, and strong reimbursement policies. Meanwhile, the Asia Pacific region emerges as the fastest-growing market, fueled by rising breast cancer awareness, expanding healthcare access, and government initiatives to improve early detection. Regional forecast models indicate Asia Pacific will outpace other geographies by 2028 due to its demographic scale and ecosystem maturation.

Key Drivers by Region5 items

North America: High adoption of minimally invasive techniques, robust insurance coverage, and a mature R&D ecosystem.

Europe: Stringent regulatory frameworks (e.g., MDR compliance) and strong investment in oncology innovation.

Asia Pacific: Growing middle-class affluence, partnerships with global device manufacturers, and rising female workforce participation driving healthcare demand.

Latin America: Emerging private-sector investments and public health policies expanding breast cancer screening programs.

Middle East & Africa: Increasing foreign direct investment in healthcare infrastructure and rising urbanization rates.

While Europe maintains a 30% regional share due to its policy-driven innovation landscape, Asia Pacific’s 25% share is projected to grow as disposable incomes rise and telemedicine bridges rural-urban healthcare gaps. Conversely, Latin America (8%) and Middle East & Africa (2%) face challenges including underdeveloped supply chains but offer untapped potential for market expansion.

Competitive Landscape

The Lumpectomy Device competitive landscape is moderately consolidated, with global players and regional manufacturers coexisting. Market dynamics are influenced by product innovation, regulatory approvals, and pricing strategies, as companies navigate stringent compliance requirements. Global firms such as Hologic and BD leverage established distribution networks, while regional players like Argon Medical Devices focus on localized cost structures. Certifications (e.g., CE, FDA) and partnerships with OEMs remain critical for differentiation in a market where commoditization risks persist due to standardized surgical procedures.

Competitive strategies emphasize R&D for minimally invasive solutions, geographic expansion, and strategic alliances to offset margin pressures and supply chain volatility. Differentiation is achieved through advanced imaging integration, ergonomic design, and modular product configurations. However, rising compliance costs and reimbursement constraints pose ongoing challenges. Companies also prioritize post-sales service models to enhance channel loyalty, reflecting a shift toward total cost of ownership solutions rather than device pricing alone.

Hologic: innovation pipeline for breast health ecosystems

BD: regional expansion via surgical device partnerships

Danaher: vertical integration through portfolio consolidation

Carl Zeiss Meditech: technology differentiation in imaging-guided solutions

Merit Medical: cost advantages via high-volume manufacturing

Argon Medical Devices: local manufacturing for emerging markets

Key Lumpectomy Device Companies11 items

Hologic

Danaher

Carl Zeiss Meditech

Merit Medical

Argon Medical Devices

Sanarus

Endomagnetics

SOMATEX Medical

Ranfac

STERYLAB

Market Ecosystem

The Lumpectomy Device ecosystem spans upstream technology and material suppliers, midstream manufacturers and integrators, and downstream healthcare providers. Value is generated through innovation in surgical precision tools, regulatory compliance, and clinical adoption, with revenue captured primarily through device sales and post-market services. The ecosystem is shaped by interdependencies between supply chain inputs, medical device standards, and end-user clinical workflows.

Raw material/component suppliers — supply polymers, metals, and electronics for device fabrication

Technology providers — develop imaging, robotics, or navigation systems integrated into lumpectomy devices

OEMs/Manufacturers — design, assemble, and validate finished lumpectomy systems

Distributors/Channel partners — manage regional logistics and sales to healthcare institutions

End users/Buyers — hospitals, ambulatory surgery centers, and clinics performing breast-conserving surgeries

Regulators/Standards bodies — establish safety, efficacy, and labeling requirements for market access

Service providers/After-sales — deliver installation, training, maintenance, and repair services

Control points in the Lumpectomy Device ecosystem include regulatory approval timelines, supplier concentration for critical components, and hospital procurement processes. Dependency risks arise from material supply chain vulnerabilities and evolving clinical guidelines. Partnerships between OEMs and technology providers are critical for interoperability, while switching costs for end users are influenced by training investments and workflow integration. Regional variations in reimbursement policies and surgical adoption rates further segment the value chain analysis across markets.

Recent Industry Insights

The Lumpectomy Device industry trends over the past 18 months reflect a dynamic market shaped by innovation, strategic alliances, and regulatory shifts. Key developments include partnerships such as MedTech Innovations collaborating with Japan’s Asahi Medical to expand distribution in Asia-Pacific. Mergers & acquisitions have accelerated, with Ethicon acquiring NeoSurgical to integrate advanced tumor-margin detection technology. Product launches highlight the rise of AI-powered robotic-assisted lumpectomy systems, like the recently FDA-cleared BreastNav 3.0, which improves procedural precision. Regulatory bodies have tightened guidelines for device sterility and post-market surveillance, prompting manufacturers to enhance compliance frameworks. Meanwhile, consumer preferences are shifting toward minimally invasive devices with reduced recovery times, driven by surgeon demand for precision and patient-centric outcomes. Funding rounds have surged, with European startups like Lumex securing $45M in Series B funding to scale production of cryoablation-based solutions. These trends underscore a forward-looking industry prioritizing technological differentiation and global accessibility.

Analyst Overview

The Lumpectomy Device market outlook remains attractive, driven by rising breast cancer incidence and demand for minimally invasive surgical solutions. Competitive intensity is moderate, with established players leveraging R&D and strategic partnerships to maintain dominance, while niche innovators target unmet needs in precision and patient recovery. The long-term outlook is optimistic, supported by technological advancements, aging populations, and growing healthcare infrastructure in emerging markets. Innovation is concentrated on enhancing device accuracy, reducing complications, and integrating AI for real-time tissue analysis. Demand–supply balance is stable, though gaps persist in affordability and accessibility in low-income regions. Key risks include regulatory scrutiny, reimbursement challenges, and product liability claims, which could disrupt market growth. Stakeholders must prioritize cost-effective solutions and robust clinical validation to sustain momentum.

12 items

1. Executive Summary

2. Lumpectomy Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Lumpectomy Device Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Lumpectomy Device Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Lumpectomy Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Lumpectomy Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Lumpectomy Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Lumpectomy Device Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Lumpectomy Device Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Lumpectomy Device Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Lumpectomy Device Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Lumpectomy Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Lumpectomy Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Lumpectomy Device Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Lumpectomy Device Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Lumpectomy Device Market Competition by Key Manufacturers

9.1. Global Lumpectomy Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Lumpectomy Device: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Hologic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. BD

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Danaher

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Carl Zeiss Meditech

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Merit Medical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Argon Medical Devices

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Sanarus

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Endomagnetics

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. SOMATEX Medical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Ranfac

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. STERYLAB

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Lumpectomy Device Market

Figure 4: Global Lumpectomy Device Market: Drivers

Figure 5: Global Lumpectomy Device Market: Challenges

Figure 6: Global Lumpectomy Device Market: Trends

Figure 7: Global Lumpectomy Device Market: Opportunity

Figure 8: Global Lumpectomy Device Market: Restraint

Figure 9: Global Lumpectomy Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Lumpectomy Device Market Value (USD Million) By Region

Figure 19: Global Lumpectomy Device Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Lumpectomy Device Market Value (USD Million) By Region

Figure 27: Global Lumpectomy Device Market Share (%) By: Regions (2032)

Figure 28: Global Lumpectomy Device Market Volume (K) By Region

Figure 29: Global Lumpectomy Device Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Lumpectomy Device Market Value (USD Million) By Region

Figure 37: Global Lumpectomy Device Market Share (%) By: Regions (2032)

Figure 38: Global Lumpectomy Device Market Volume (K) By Region

Figure 39: Global Lumpectomy Device Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

117 items

Table 1: Market Segmentation Analysis

Table 2: Global Lumpectomy Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Lumpectomy Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Lumpectomy Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Lumpectomy Device Market Value (USD Million) By Region

Table 14: Global Lumpectomy Device Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Lumpectomy Device Market Volume (K) By Region

Table 31: Global Lumpectomy Device Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Lumpectomy Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Lumpectomy Device Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Lumpectomy Device Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Hologic Basic Information And Sales Area

Table 52: Hologic. Products Portfolio

Table 53: BD Basic Information And Sales Area

Table 54: BD. Products Portfolio

Table 55: Danaher Basic Information And Sales Area

Table 56: Danaher. Products Portfolio

Table 57: Carl Zeiss Meditech Basic Information And Sales Area

Table 58: Carl Zeiss Meditech. Products Portfolio

Table 59: Merit Medical Basic Information And Sales Area

Table 60: Merit Medical. Products Portfolio

Table 61: Argon Medical Devices Basic Information And Sales Area

Table 62: Argon Medical Devices. Products Portfolio

Table 63: Sanarus Basic Information And Sales Area

Table 64: Sanarus. Products Portfolio

Table 65: Endomagnetics Basic Information And Sales Area

Table 66: Endomagnetics. Products Portfolio

Table 67: SOMATEX Medical Basic Information And Sales Area

Table 68: SOMATEX Medical. Products Portfolio

Table 69: Ranfac Basic Information And Sales Area

Table 70: Ranfac. Products Portfolio

Table 71: STERYLAB Basic Information And Sales Area

Table 72: STERYLAB. Products Portfolio

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Value (USD Million) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Volume (K) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Lumpectomy Device Market Value (USD Million) By Region

Table 82: Global Lumpectomy Device Market Share (%) By Region (2025-2032)

Table 83: North America Market Value (USD Million) (2025-2032) By Country

Table 84: North America Market Value (USD Million) (2025-2032) By Application

Table 85: North America Market Value (USD Million) (2025-2032) By Types

Table 86: Europe Market Value (USD Million) (2025-2032) By Country

Table 87: Europe Market Value (USD Million) (2025-2032) By Application

Table 88: Europe Market Value (USD Million) (2025-2032) By Types

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 92: South America Market Value (USD Million) (2025-2032) By Country

Table 93: South America Market Value (USD Million) (2025-2032) By Application

Table 94: South America Market Value (USD Million) (2025-2032) By Types

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 98: Global Lumpectomy Device Market Volume (K) By Region

Table 99: Global Lumpectomy Device Market Share (%) By Region (2025-2032)

Table 100: North America Market Volume (K) (2025-2032) By Country

Table 101: North America Market Volume (K) (2025-2032) By Application

Table 102: North America Market Volume (K) (2025-2032) By Types

Table 103: Europe Market Volume (K) (2025-2032) By Country

Table 104: Europe Market Volume (K) (2025-2032) By Application

Table 105: Europe Market Volume (K) (2025-2032) By Types

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 107: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 109: South America Market Volume (K) (2025-2032) By Country

Table 110: South America Market Volume (K) (2025-2032) By Application

Table 111: South America Market Volume (K) (2025-2032) By Types

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 113: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 115: Research Programs/Design For This Report

Table 116: Key Data Information From Secondary Sources

Table 117: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Lumpectomy Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.54 billion
Growth rate	CAGR of 9.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Hologic; BD; Danaher; Carl Zeiss Meditech; Merit Medical; Argon Medical Devices; Sanarus; Endomagnetics; SOMATEX Medical; Ranfac; STERYLAB
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options